HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphomatoid papulosis. Characterization of skin infiltrates by monoclonal antibodies.

Abstract
Cryostat sections from fully developed papular lesions of lymphomatoid papulosis (histologic subtype A or B) have been examined by immunoenzymatic staining with 24 monoclonal antibodies against lymphoid cells and their subsets. The lesions demonstrated essentially identical cellular compositions and consisted of T-lymphocytes with a peripheral phenotype (Lyt3+, anti-Leu-4+, OKT6-), macrophages (HLA-DR+, EB11+, OKM1+), and Langerhans cells (HLA-DR+, OKT6+). T-helper/inducer cells (anti-Leu-3+) usually dominated over T-suppressor/cytotoxic cells (anti-Leu-2+). In all cases, proportions of the infiltrating T-cells expressed markers associated with activation (HLA-DR, the OKT1O antigen, interleukin-2 receptor) or proliferation (transferrin receptor, the Ki-67 antigen) of lymphoid cells. Furthermore, the infiltrates contained clusters and/or sheets of large cells reactive with antibodies (Ki-1, Ki-24, Ki-27), which recognize Hodgkin's and Reed-Sternberg cells. These data indicate an origin of the cellular infiltrate from transformed or activated lymphoid cells and suggest an interrelationship of lymphomatoid papulosis to Hodgkin's disease.
AuthorsE Ralfkiaer, H Stein, G L Wantzin, K Thomsen, N Ralfkiaer, D Y Mason
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 84 Issue 5 Pg. 587-93 (Nov 1985) ISSN: 0002-9173 [Print] England
PMID3904400 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
Topics
  • Adult
  • Antibodies, Monoclonal
  • Female
  • Hodgkin Disease (pathology)
  • Humans
  • Immunoenzyme Techniques
  • Langerhans Cells (classification)
  • Lymphoma (immunology, pathology)
  • Macrophages (classification)
  • Male
  • Middle Aged
  • Skin Neoplasms (immunology, pathology)
  • T-Lymphocytes (classification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: